Physiology of bone

Endocrine Development

Volumn 16, Issue , 2009, Pages 32-48

  Grabowski, Peter ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; COLLAGEN TYPE 1; COLLAGEN TYPE 2; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHATE; VITAMIN D;

ADAPTATION; BONE; BONE DEVELOPMENT; BONE MARROW; BONE MATRIX; BONE METABOLISM; BONE MINERAL; BONE STRENGTH; CALCIUM BLOOD LEVEL; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL FUNCTION; CYTOLOGY; DIET; EXERCISE; HEMATOPOIETIC CELL; HORMONE ACTION; HUMAN; LOAD CARRYING CAPACITY; LOCOMOTION; MINERAL METABOLISM; MOLECULAR DYNAMICS; NERVOUS SYSTEM; NUTRITION; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; PHOSPHATE BLOOD LEVEL; PHOSPHATE TRANSPORT; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

BONE AND BONES; BONE DEVELOPMENT; BONE MATRIX; CARTILAGE; CELL DIFFERENTIATION; CHILD; EXERCISE; HUMANS; MINERALS; NERVOUS SYSTEM PHYSIOLOGICAL PHENOMENA; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; OSTEOBLASTS; OSTEOCLASTS; OSTEOCYTES; WEIGHT-BEARING;

EID: 68149154621     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000223687     Document Type: Review

References (55)

1. Frost HM: From Wolff's law to the Utah paradigm: insights about bone physiology and its clinical applications. Anat Rec 2001;262:398-419.
2. Frost HM: Bone's mechanostat: a 2003 update. Anat Rec A Discov Mol Cell Evol Biol 2003;275:1081- 1101.
3. Jee WS: Principles in bone physiology. J Musculoskelet Neuronal Interact 2000;1:11-13.
4. Duncan RL, Turner CH: Mechanotransduction and the functional response of bone to mechanical strain. Calcif Tissue Int 1995;57:344-358.
5. Ducy P, Karsenty G: Genetic control of cell differentiation in the skeleton. Curr Opin Cell Biol 1998;10: 614-619.
6. Chen D, Zhao M, Mundy GR: Bone morphogenetic proteins. Growth Factors 2004;22:233-241.
7. Xu X, Weinstein M, Li C, Deng C: Fibroblast growth factor receptors (FGFRs) and their roles in limb development. Cell Tissue Res 1999;296:33-43.
8. Iwamoto M, Enomoto-Iwamoto M, Kurisu K: Actions of hedgehog proteins on skeletal cells. Crit Rev Oral Biol Med 1999;10:477-486.
9. Church VL, Francis-West P: Wnt signalling during limb development. Int J Dev Biol 2002;46:927-936.
10. Karaplis AC: Embryonic development of bone and the molecular regulation of intramembranous and endochondral bone formation; in Bilezikian J P, Raisz LG, Rodan GA (eds): Principles of Bone Biology. San Diego, Academic Press, 2002, pp 33-58.
11. Oreffo RO, Cooper C, Mason C, Clements M: Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential. Stem Cell Rev 2005;1: 169-178.
12. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, et al: Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 1997;89:773-779.
13. Otto F, Thornell A P, Crompton T, Denzel A, Gilmour KC, Rosewell IR, et al: Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997;89:765-771.
14. Nakashima K, Zhou X, Kunkel G, et al: The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002;108:17-29.
15. Lee B, Thirunavukkarasu K, Zhou L, et al: Missense mutations abolishing DNA binding of the osteo-blast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat Genet 1997;16:307- 310.
16. Komori T, Yagi H, Nomura S, et al: Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997;89:755-764.
17. Kobayashi H, Gao Y, Ueta C, Yamaguchi A, Komori T: Multilineage differentiation of Cbfa1-deficient calvarial cells in vitro. Biochem Biophys Res Commun 2000;273:630-636.
18. Baron R, Rawadi G: Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 2007;148:2635-2643.
19. Glass DA, Bialek P, Ahn JD, et al: Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 2005;8:751-764.
20. Kadler KE, Baldock C, Bella J, Boot-Handford RP: Collagens at a glance. J Cell Sci 2007;120:1955- 1958.
21. Byers PH: Collagens: building blocks at the end of the development line. Clin Genet 2000;58:270-279.
22. Balemans W, Ebeling M, Patel N, et al: Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 2001;10:537-543.
23. Brunkow ME, Gardner JC, Van Ness J, et al: Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 2001;68:577-589.
24. Kusu N, Laurikkala J, Imanishi M, et al: Sclerostin is a novel secreted osteoclast-derived bone morphoge-netic protein antagonist with unique ligand specificity. J Biol Chem 2003;278:24113-24117.
25. Boyle WJ, Simonet WS, Lacey DL: Osteoclast differentiation and activation. Nature 2003;423:337- 342.
26. Del Fattore A, Cappariello A, Teti A: Genetics, pathogenesis and complications of osteopetrosis. Bone 2008;42:19-29.
27. Sobacchi C, Frattini A, Guerrini MM, et al: Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nat Genet 2007;39:960-962.
28. Guerrini MM, Sobacchi C, Cassani B, et al: Human osteoclast-poor osteopetrosis with hypogamma-globulinemia due to TNFRSF11A (RANK) mutations. Am J Hum Genet 2008;83:64-76.
29. Nijenhuis T, Hoenderop JG, Bindels RJ: TRPV5 and TRPV6 in Ca(2+) (re)absorption: regulating Ca(2+) entry at the gate. Pflügers Arch 2005;451:181-192.
30. ADHR Consortium: Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 2000;26:345-348.
31. Shimada T, Kakitani M, Yamazaki Y, et al: Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 2004;113:561-568.
32. Sitara D, Razzaque MS, Hesse M, et al: Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 2004;23:421-432.
33. Urakawa I, Yamazaki Y, Shimada T, et al: Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 2006;444:770-774.
34. Chang Q, Hoefs S, van der Kemp AW, Topala CN, Bindels RJ, Hoenderop JG: The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 2005;310:490-493.
35. Jones KB, Mollano AV, Morcuende JA, Cooper RR, Saltzman CL: Bone and brain: a review of neural, hormonal, and musculoskeletal connections. Iowa Orthop J 2004;24:123-132.
36. Mason DJ, Suva LJ, Genever PG, et al: Mechanically regulated expression of a neural glutamate transporter in bone: a role for excitatory amino acids as osteotropic agents? Bone 1997;20:199-205.
37. Laketic-Ljubojevic I, Suva LJ, Maathuis FJ, Sanders D, Skerry TM: Functional characterization of N-methyl-D-aspartic acid-gated channels in bone cells. Bone 1999;25:631-637.
38. Ducy P, Amling M, Takeda S, et al: Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000;100:197- 207.
39. Takeda S, Elefteriou F, Levasseur R, et al: Leptin regulates bone formation via the sympathetic nervous system. Cell 2002;111:305-317.
40. Currey JD: Bones: Structure and Mechanics. Princeton, Princeton University Press, 2002.
41. Wolff J: Das Gesetz der Transformation der Knochen. Berlin, Hirschwald, 1892.
42. Haapasalo H, Kontulainen S, Sievanen H, Kannus P, Jarvinen M, Vuori I: Exercise-induced bone gain is due to enlargement in bone size without a change in volumetric bone density: a peripheral quantitative computed tomography study of the upper arms of male tennis players. Bone 2000;27:351-357.
43. Clark EA, Goodship AE, Lanyon LE: Locomotor bone strain as the stimulus for bone's mechanical adaptability. J Physiol 1975;245:57P.
44. Skerry TM: One mechanostat or many? Modifications of the site-specific response of bone to mechanical loading by nature and nurture. J Musculoskelet Neuronal Interact 2006;6:122-127.
45. Rubin J, Rubin C, Jacobs CR: Molecular pathways mediating mechanical signaling in bone. Gene 2006; 367:1-16.
46. Malone AM, Anderson CT, Tummala P, Kwon RY, Johnston TR, Stearns T et al.: Primary cilia mediate mechanosensing in bone cells by a calcium-independent mechanism. Proc Natl Acad Sci USA 2007; 104:13325-13330.
47. Bailey DA: The Saskatchewan Pediatric Bone Mineral Accrual Study: bone mineral acquisition during the growing years. Int J Sports Med 1997; 18(suppl 3):S191-S194.
48. Bailey DA, Martin AD, McKay HA, Whiting S, Mirwald R: Calcium accretion in girls and boys during puberty: a longitudinal analysis. J Bone Miner Res 2000;15:2245-2250.
49. Hui SL, Slemenda CW, Johnston CC Jr: The contribution of bone loss to postmenopausal osteoporosis. Osteoporos Int 1990;1:30-34.
50. Seeman E: Reduced bone density in women with fractures: contribution of low peak bone density and rapid bone loss. Osteoporos Int 1994;4(suppl 1):15-25.
51. Hind K, Burrows M: Weight-bearing exercise and bone mineral accrual in children and adolescents: a review of controlled trials. Bone 2007;40:14-27.
52. Cooper C, Westlake S, Harvey N, Javaid K, Dennison E, Hanson M: Review: developmental origins of osteoporotic fracture. Osteoporos Int 2006;17:337- 347.
53. Loud KJ, Gordon CM: Adolescent bone health. Arch Pediatr Adolesc Med 2006;160:1026-1032.
54. Ducher G, Bass SL: Exercise during growth: compelling evidence for the primary prevention of osteoporosis? BoneKEy - Osteovision 2007;4:171- 180.
55. Superti-Furga A, Unger S: Nosology and classification of genetic skeletal disorders: 2006 revision. Am J Med Genet A 2007;143:1-18.